# Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

> **NCT05496491** · NA · RECRUITING · sponsor: **Larissa University Hospital** · enrollment: 84 (estimated)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **RADIATION:** Neoadjuvant Chemoradiotherapy
- **DRUG:** Adjuvant Chemotherapy
- **DRUG:** Consolidation Chemotherapy

## Key facts

- **NCT ID:** NCT05496491
- **Lead sponsor:** Larissa University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-30
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05496491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05496491, "Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05496491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*